<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Eddie Eddie Ellison,  III</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">January 1, 1959 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>19401 NW 18TH AVE<br/>MIAMI GARDENS, FL 33056, USA<br/>Effective Date: April 26, 2022 <br/><br/> Previous Address:<br/>16030 NW 17TH PL<br/>OPA LOCKA, FL 33054, USA<br/>Effective Date: April 26, 2022 <br/>Expiration Date: April 25, 2022 <br/><br/> Previous Address:<br/>16030 NW 17TH PL<br/>OPA LOCKA, FL 33054<br/>Effective Date: October 19, 2011 <br/>Expiration Date: April 25, 2022 <br/><br/>Mobile Phone:  +1-305-962-5908<br/>Email:  Kethay@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">MEM4FJV0PPR6G6M 1.2.840.114350.1.13.253.2.7.3.688884.100<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.253.2.7.8.688883.405487492</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">April 22, 2024, 13:46:03 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format"> of Memorial Healthcare System (MHS)</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 10.5</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">5068770080 1.2.840.114350.1.13.253.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Office Visit</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From April 26, 2022, 14:30:00 -0400  to April 26, 2022, 15:11:16 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">Memorial Division of Urology at MHW 301 of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Jonathan Silberstein of Memorial Healthcare System (MHS)</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>20801 BISCAYNE BLVD<br/>SUITE 203<br/>AVENTURA, FL 33180, USA<br/><br/>Work Phone:  +1-305-682-2580<br/>Fax:  +1-305-705-1677<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact (Daughter)</span></td><td class="td_header_role_value">Schketha Ellison<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Mobile Phone:  +1-305-409-8088<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Emergency contact (Daughter)</span></td><td class="td_header_role_value">Anaya Frazier<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Mobile Phone:  +1-305-218-6752<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Him Director Autogenerated signed at April 22, 2024, 13:46:03 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Memorial Healthcare System (MHS)</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>3501 Johnson St<br/>Hollywood, FL 33021, USA<br/><br/><br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Referral</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Last Filed Vital Signs</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Visit Diagnoses</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Referral</a></h3><div><ul><li>MRI/CAT Scan (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Prostate cancer (HCC Risk Code)</p><p>PSA elevation</p><p>Lower urinary tract symptoms (LUTS)</p><br/><p>Procedures</p><p>MRI pelvis/prostate w/wo IV contrast</p><p>PR MRI, PELVIS, COMBO</p></td><td><p>Silberstein, Jonathan, MD</p><p>20801 BISCAYNE BLVD</p><p>SUITE 203</p><p>AVENTURA, FL 33180</p><p>Phone: 305-682-2580</p><p>Fax: 305-705-1677</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>7917789</td><td class="xflagData">Closed</td><td/><td>4/26/2022</td><td>7/25/2022</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by Jonathan Silberstein MD at 04/26/2022  3:36 PM EDT</p></li></ul></div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv3"><td ID="reasonrfv3">New Patient</td><td/></tr></tbody></table></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter4" class="xRowNormal"><td>04/26/2022  2:30 PM EDT</td><td ID="encounter4type">Office Visit</td><td><p>Memorial Division of Urology at MHW 301</p><p>601 N Flamingo Road,</p><p>Suite 301</p><p>PEMBROKE PINES, FL 33028</p><p>305-682-2580</p></td><td><p>Silberstein, Jonathan, MD</p><p>20801 BISCAYNE BLVD</p><p>SUITE 203</p><p>AVENTURA, FL 33180</p><p>305-682-2580 (Work)</p><p>305-705-1677 (Fax)</p></td><td><content>Prostate cancer (HCC Risk Code) (Primary Dx); <br/>PSA elevation; <br/>Lower urinary tract symptoms (LUTS)</content></td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist11"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist11packsperday"/><td/><td/></tr><tr ID="sochist11smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex14"><td>Sex Assigned at Birth</td><td ID="BirthSex14Value">Not on file</td><td/></tr><tr ID="GenderIdentity12"><td>Gender Identity</td><td ID="GenderIdentity12Value">Not on file</td><td/></tr><tr ID="SexualOrientation13"><td>Sexual Orientation</td><td ID="SexualOrientation13Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">170</span>/<span class="content_span">105</span></td><td>04/26/2022  2:36 PM EDT</td><td/></tr><tr ID="pulse_5721906960" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>75</td><td>04/26/2022  2:36 PM EDT</td><td/></tr><tr ID="temp_" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>-</td><td>-</td><td/></tr><tr ID="resp_" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>-</td><td>-</td><td/></tr><tr ID="SpO2_" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>-</td><td>-</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5721906960" class="xRowNormal"><td class="xcellHeader">Weight</td><td>106 kg (233 lb 11 oz)</td><td>04/26/2022  2:36 PM EDT</td><td/></tr><tr ID="height_5721906960" class="xRowAlt"><td class="xcellHeader">Height</td><td>182.9 cm (6' 0.01")</td><td>04/26/2022  2:36 PM EDT</td><td/></tr><tr ID="bmi_5721906960" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>31.69</td><td>04/26/2022  2:36 PM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>Jonathan Silberstein, MD - 04/26/2022  2:30 PM EDT: <content><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Urology CONSULTATIONNew Patient visit  <br/>Jonathan Silberstein, MD<br/><br/>Eddie Ellison III<br/>2137443<br/>4/26/2022<br/><br/>Subjective <br/>History of present illness  <br/>Eddie Ellison III is here with a chief complaint of prostate cancer.<br/><br/>Is a very nice patient is a patient of David Robbins seen at urologic consultants of Florida.  The patient had a PSA of 7 and as a result underwent a prostate biopsy which revealed 2 cores of Gleason 3+3 and 3+4 in the right medial mid and the right medial apex.  The biopsy showed that the prostate volume was about 76 cc and the cores had 15 and 10% of prostate cancer on them respectively.<br/><br/>The patient's daughter is a bone marrow transplant survivor and is enthusiastic about the patient having surgery Dr. Robbins was in there is he has took about the patient getting radiotherapy with Lupron and the patient is here to discuss all of this.<br/><br/>CURRENT Medications  <br/>Patient has a current medication list which includes the following prescription(s): amlodipine - Take 10 mg by mouth once daily, lisinopril - Take 40 mg by mouth once daily, tamsulosin - Take 0.4 mg by mouth once daily, benazepril-hydrochlorthiazide - Take 1 tablet by mouth once daily, and albuterol - Inhale 1 puff into the lungs every 4 hours as needed for Wheezing or Shortness of Breath (as needed for cough).<br/><br/>REVIEW OF SYSTEMS<br/>ROS<br/><br/> Objective <br/><br/>Physical Exam<br/>Constitutional:  <br/>   General: He is not in acute distress.<br/>   Appearance: He is not ill-appearing, toxic-appearing or diaphoretic. <br/>HENT: <br/>   Head: Normocephalic. <br/>   Nose: No congestion. <br/>   Mouth/Throat: <br/>   Mouth: Mucous membranes are moist. <br/>   Pharynx: Oropharynx is clear. <br/>Eyes: <br/>   Extraocular Movements: Extraocular movements intact. <br/>Cardiovascular: <br/>   Rate and Rhythm: Normal rate. <br/>   Pulses: Normal pulses. <br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. <br/>Abdominal: <br/>   General: Abdomen is flat. There is no distension. <br/>   Palpations: Abdomen is soft. <br/>   Tenderness: There is no abdominal tenderness. There is no guarding. <br/>Genitourinary:<br/>   Comments: Because of his recent prostate biopsy done in March 2022 have elected to defer prostate exam until the MRI is obtained.<br/>Musculoskeletal:    <br/>   General: Normal range of motion. <br/>   Cervical back: Normal range of motion. <br/>Skin:<br/>   General: Skin is warm and dry. <br/>Neurological: <br/>   General: No focal deficit present. <br/>   Mental Status: He is alert and oriented to person, place, and time. <br/>Psychiatric:    <br/>   Mood and Affect: Mood normal. <br/><br/> <br/><br/>I reviewed the patients relevant laboratory values and imaging. <br/><br/>  Assessment/PLAN:<br/>Mr. Ellison has prostate cancer and after discussion of his 4 options which would include active surveillance, radiation without Lupron, radiation with Lupron or surgical extirpation the patient is leaning much more heavily towards active surveillance.<br/><br/>The patient admits that his PSA has been 7 for several years prior to his evaluation by Dr. Robbins.<br/><br/>The patient understands that any intervention may diminish his quality of life and poses some risk.  Patient additionally understands that active surveillance for Gleason 3+4 favorable intermediate risk prostate cancer in an African-American man is reasonable however there are risks of allowing his cancer to grow and potentially spread.  Despite these risk the patient would like to take an active surveillance noninterventional type approach for now I am tentatively excepting of this approach over the patient is going to get an MRI of the prostate in 2 months after his prostate is healed from his prior biopsy and the patient is going to get a decipher genomic score based on his prior biopsy should either these show that the patient is higher risk than presumed I will feel less inclined for active surveillance and encouraged him towards treatment.<br/><br/>Patient understands this plan and wishes to proceed as discussed<br/><br/>1. Prostate cancer (HCC Risk Code) (Primary)<br/>-     MRI pelvis/prostate w/wo IV contrast; Future<br/>2. PSA elevation<br/>-     MRI pelvis/prostate w/wo IV contrast; Future<br/>3. Lower urinary tract symptoms (LUTS)<br/>-     MRI pelvis/prostate w/wo IV contrast; Future<br/><br/> <br/><br/></content><br/><span class="xLabel">Electronically signed by Jonathan Silberstein, MD at 04/26/2022  3:41 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure33"><td><span class="content_span">MRI pelvis/prostate w/wo IV contrast</span></td><td>Imaging</td><td>Routine</td><td><p>Prostate cancer</p><p>PSA elevation</p><p>Lower urinary tract symptoms (LUTS)</p></td><td ID="procedure33schedule">Expected: 06/26/2022, Expires: 04/26/2023</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx5" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HCC Risk Code)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">PSA elevation</span></p><p>Elevated prostate specific antigen (PSA)</p></td></tr><tr ID="vdx7" class="xRowNormal"><td><p><span class="content_span">Lower urinary tract symptoms (LUTS)</span></p><p>Other symptoms involving urinary system</p></td></tr></tbody></table>documented in this encounter</div><br/><br/></body></html>